Logo
x

Search

Subscribe Now

Caliway Biopharmaceuticals

Caliway Biopharmaceuticals’ CBL-514 Receives the EMA’s Orphan Drug Designation for the Treatment of Dercum’s Disease

Caliway Biopharmaceuticals’ CBL-514 Receives the EMA’s Orphan Drug Designation for the Treatment of Dercum’s Disease

  • November 13, 2024
Caliway Reports the IND Acceptance of CBL-514 by the US FDA for the Treatment of Dercum's Disease

Caliway Reports the IND Acceptance of CBL-514 by the US FDA for the Treatment of Dercum's Disease

  • January 8, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.